Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02807441Phase 3Withdrawn
Phase 3, randomised trial of aspirin in thrombosis (3 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoints: Amount of intraoperative blood loss and Amount of postoperative blood loss. Planned start Jul 2016; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02807441.